Friday 6 November 2026 Export BIO.B’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue: +0.52%
EPS: +234.9%
Free cash flow: +8.07%
Total debt: +0.11%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

379.50 15.35 +4.22%

Follow BIO.B

Alert me

Market cap: $10.3B
P/E: 9.9×
Fwd P/E: —
Dividend yield: —
F-score: 5/9
Altman Z: 3.24
Beneish M: −2.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bio-Rad Laboratories, Inc. (BIO.B) P/S ratio

Alert me on P/S ratio

As of 27 October 2026, Bio-Rad Laboratories, Inc. (BIO.B) trades at a P/S ratio of 3.9×. Over the past ten years it has ranged from 1.5× (January 2015) to 8.5× (September 2021); the current reading is higher than 60% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BIO.B/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Bio-Rad Laboratories, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BIO.B/metrics/ps-ratio">Bio-Rad Laboratories, Inc. (BIO.B) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	3.3×	(8.39%)
FY2024	3.6×	2.09%
FY2023	3.5×	(18.48%)
FY2022	4.3×	(41.71%)
FY2021	7.4×	9.90%
FY2020	6.7×	40.71%
FY2019	4.8×	59.19%
FY2018	3.0×	(8.36%)
FY2017	3.3×	25.45%
FY2016	2.6×	31.02%

Period	P/S ratio	Change
Sep 2026	3.8×	23.13%
Jun 2026	3.1×	5.74%
Mar 2026	2.9×	(11.67%)
Dec 2025	3.3×	9.34%
43 more quarters	Free account

Against its own ten years

Low 1.5× High 8.5×

Ten-year median 3.6×

Current reading's percentile 56

Company	P/S ratio
SNN Smith & Nephew SNATS, Inc. compare	1.4×
BRKR Bruker Corporation compare	2.5×
PODD Insulet Corporation compare	3.4×
GMED Globus Medical, Inc. compare	3.5×
BIO Bio-Rad Laboratories, Inc. compare	3.8×
BIO.B Bio-Rad Laboratories, Inc.	3.9×
PEN Penumbra, Inc. compare	8.1×
TXG 10x Genomics compare	12.4×
GKOS Glaukos Corporation compare	18.8×
Medical Devices industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Bio-Rad Laboratories, Inc. (BIO.B) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on BIO.B

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on BIO.B

Stockrow Weekly